Unknown

Dataset Information

0

Delivery of AAV2/9-microdystrophin genes incorporating helix 1 of the coiled-coil motif in the C-terminal domain of dystrophin improves muscle pathology and restores the level of ?1-syntrophin and ?-dystrobrevin in skeletal muscles of mdx mice.


ABSTRACT: Duchenne muscular dystrophy is a severe X-linked inherited muscle wasting disorder caused by mutations in the dystrophin gene. Adeno-associated virus (AAV) vectors have been extensively used to deliver genes efficiently for dystrophin expression in skeletal muscles. To overcome limited packaging capacity of AAV vectors (<5?kb), truncated recombinant microdystrophin genes with deletions of most of rod and carboxyl-terminal (CT) domains of dystrophin have been developed. We have previously shown the efficiency of mRNA sequence-optimized microdystrophin (?R4-23/?CT, called MD1) with deletion of spectrin-like repeat domain 4 to 23 and CT domain in ameliorating the pathology of dystrophic mdx mice. However, the CT domain of dystrophin is thought to recruit part of the dystrophin-associated protein complex, which acts as a mediator of signaling between extracellular matrix and cytoskeleton in muscle fibers. In this study, we extended the ?R4-23/?CT microdystrophin by incorporating helix 1 of the coiled-coil motif in the CT domain of dystrophin (MD2), which contains the ?1-syntrophin and ?-dystrobrevin binding sites. Intramuscular injection of AAV2/9 expressing CT domain-extended microdystrophin showed efficient dystrophin expression in tibialis anterior muscles of mdx mice. The presence of the CT domain of dystrophin in MD2 increased the recruitment of ?1-syntrophin and ?-dystrobrevin at the sarcolemma and significantly improved the muscle resistance to lengthening contraction-induced muscle damage in the mdx mice compared with MD1. These results suggest that the incorporation of helix 1 of the coiled-coil motif in the CT domain of dystrophin to the microdystrophins will substantially improve their efficiency in restoring muscle function in patients with Duchenne muscular dystrophy.

SUBMITTER: Koo T 

PROVIDER: S-EPMC3225045 | biostudies-literature | 2011 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Delivery of AAV2/9-microdystrophin genes incorporating helix 1 of the coiled-coil motif in the C-terminal domain of dystrophin improves muscle pathology and restores the level of α1-syntrophin and α-dystrobrevin in skeletal muscles of mdx mice.

Koo Taeyoung T   Malerba Alberto A   Athanasopoulos Takis T   Trollet Capucine C   Boldrin Luisa L   Ferry Arnaud A   Popplewell Linda L   Foster Helen H   Foster Keith K   Dickson George G  

Human gene therapy 20110525 11


Duchenne muscular dystrophy is a severe X-linked inherited muscle wasting disorder caused by mutations in the dystrophin gene. Adeno-associated virus (AAV) vectors have been extensively used to deliver genes efficiently for dystrophin expression in skeletal muscles. To overcome limited packaging capacity of AAV vectors (<5 kb), truncated recombinant microdystrophin genes with deletions of most of rod and carboxyl-terminal (CT) domains of dystrophin have been developed. We have previously shown t  ...[more]

Similar Datasets

| S-EPMC2581714 | biostudies-other
| S-EPMC6251231 | biostudies-literature
| S-EPMC2835139 | biostudies-literature
| S-EPMC4786912 | biostudies-literature
| S-EPMC2671676 | biostudies-literature
| S-EPMC3360968 | biostudies-literature
| S-EPMC6371207 | biostudies-literature
| S-EPMC2938373 | biostudies-literature
| S-EPMC2139947 | biostudies-literature
| S-EPMC3188746 | biostudies-literature